Download presentation
Presentation is loading. Please wait.
1
Bortezomib 1nM PU.1 GAPDH KMS12PE U266 U937 Supplemental Figure S1
2
A U266 Supplemental Figure S2 No treatment Lenalidomide 1µM
PU.1-binding site Lenalidomide 1µM Supplemental Figure S2
3
B KMS12PE Supplemental Figure S2 No treatment Lenalidomide 1µM
PU.1-binding site Lenalidomide 1µM Supplemental Figure S2
4
Supplementary Figure S3
DMSO Lenalidomide Pomalidomide RG108 1 µM Supplementary Figure S3
5
Supplemental Figure S4
6
A U266 CDKN1A CDKN1C SOCS1 SOCS3 Supplemental Figure S5
7
KMS12PE B CDKN1A CDKN1C SOCS1 SOCS3 Supplemental Figure S5
Similar presentations
